Sign in
4

Changes in Ownership

Alkermes plc. Filed Acc 0001520262-25-000008

EVP R&D, Chief Medical Officer sold 9,000 shares at $31.53 ($283,776)

  • EVP R&D, Chief Medical Officer acquired 5,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Hopkinson Craig C. · EVP R&D, Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-10-15 Exercise or conversion : show line 1 in the form 10b5-1 +5,000 $19.34 $96,700 82,740 D
2025-10-15 Sale : show line 2 in the form 10b5-1 −9,000 $31.53 $283,776 73,740 D
Open-market sales · 9,000 sh · avg $31.53 · $283,776

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-10-15 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Buy) −5,000 45,104 D
Loading xslF345X05/form4.xml…